Video Experimental Relacionado
Updated: Jul 20, 2026

12:38
Detection and Isolation of Viable Mouse IL-17-Secreting T Cells
Published on: December 18, 2008
Síndrome de eosinophilia-mialgia en pacientes expuestos al L-triptófano
M L Kamb1, J J Murphy, J L Jones
1Centers for Disease Control, Public Health Service, US Department of Health and Human Services, Atlanta, Ga. 30333.
JAMA
|January 1, 1992
Resumen
Las dosis altas de L-triptófano, particularmente la marca A, aumentaron significativamente el riesgo de desarrollar síndrome de eosinofilia-mialgia. Este estudio destaca la dosis como un factor clave en las enfermedades asociadas al L-triptófano.
Área de la Ciencia:
- Epidemiología La epidemiología.
- Toxicología Toxicología.
- La medicina clínica es la medicina clínica.
Sus antecedentes:
- El síndrome de eosinophilia-mialgia (EMS) es una afección grave relacionada con la suplementación con L-triptófano.
- Comprender la incidencia, los factores de riesgo y la presentación clínica del SME es crucial para la salud pública.
Objetivo del estudio:
- Para determinar la incidencia de EMS en una población expuesta al L-triptófano.
- Identificar los factores de riesgo, incluidas marcas y dosis específicas, asociados con el SME.
- Para describir el espectro clínico de enfermedades relacionadas con el uso de L-triptófano.
Principales métodos:
- Se llevaron a cabo estudios retrospectivos de cohortes y estudios de casos y controles anidados.
- La recopilación de datos incluyó revisiones de gráficos y entrevistas con pacientes (en persona y por teléfono).
- Se realizó un estudio descriptivo del curso clínico de los usuarios de L-triptófano.
Principales resultados:
- Entre los 418 usuarios de L-triptófano entrevistados, el 11% tenía EMS definido y el 16% tenía posible EMS.
- El uso de una marca específica (marca A) se asoció fuertemente con la EMS, con un riesgo que aumentaba con la dosis.
- Las dosis más altas de la marca A L-triptófano (más de 4000 mg / día) llevaron a tasas significativamente más altas de EMS definitivo o posible.
Conclusiones:
- La dosis de L-triptófano es el principal predictor de la EMS, lo que sugiere la contaminación en ciertos productos.
- Una proporción significativa de individuos expuestos puede desarrollar EMS, y las definiciones estrictas de casos podrían subestimar la incidencia real.
Más Videos Relacionados
Videos de Conceptos Relacionados
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Giardiasis
Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...

